← miss ducky

Periarticular Neurofascial Dextrose Prolotherapy Versus Physiotherapy for the Treatment of Chronic Rotator Cuff Tendinopathy: Randomized Clinical Trial

omuz   Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021 · PMID 32975923

Rotator cuff tendinopathy is a common cause of shoulder pain. We aimed to compare periarticular (neurofascial) dextrose prolotherapy versus physiotherapy for treatment of chronic rotator cuff tendinopathy in the short term. We carried out a randomized clinical trial with 2 arms at a university hospital. In total, 66 patients with chronic rotator cuff tendinopathy, proven by magnetic resonance imaging, were randomly allocated to 2 groups. The outcomes were change in shoulder pain intensity (primary) and disability (secondary) index using a questionnaire for Shoulder Pain and Disability Index. For physiotherapy, participants received superficial heat, transcutaneous electrical nerve stimulation, and pulsed ultrasound. Also, they carried out an exercise program, 10 sessions of 30 minutes for 3 weeks. For prolotherapy, we used 8 mL of 12.5% dextrose and 40 mg of 2% lidocaine. The mixture was injected 2 times with 1-week interval superficially around the shoulder joint and to tender points along the suprascapular nerve. Neurofascial dextrose was more effective than physiotherapy for alleviating pain in 2 weeks (p < 0.001), and they were similar 3 months after the interventions (p = 0.055). For disability, dextrose was more effective than physiotherapy 2 weeks and 3 months (both p < 0.001) after the interventions. However, the changes in the physiotherapy group seemed to be more sustained. Both interventions are effective for the short-term management of rotator cuff tendinopathy. However, prolotherapy is more successful as the initial treatment. Besides, the treatment time is much shorter for dextrose prolotherapy compared with physiotherapy.

bu makaleden üretilen sorular (4)

omuz orta

Mofrad ve ekibinin periartikuler/neurofasial dekstroz protokolu uygulanacak hasta hazirlaniyor.

Mofrad ve ekibinin periartikuler neurofasial dekstroz protokolunde kullanilan dekstroz konsantrasyonu ve toplam volum nedir?

cevabı gör

doğru cevap: 8 mL %12.5 dekstroz

açıklama: Neurofasial protokolde 8 mL %12.5 dekstroz + 40 mg %2 lidokain, omuz cevresine ve suprascapular sinir boyunca hassas noktalara yuzeyel enjekte edilmistir.

Mofrad MK, Rezasoltani Z, Dadarkhah A, et al. J Clin Rheumatol 2021;27(4):e134-e138 PMID 32975923

omuz orta

Neurofasial dekstroz protokolu ile tedavi edilecek hastaya seans plani anlatiliyor.

Mofrad neurofasial dekstroz protokolunde seans sayisi ve araligi nedir?

cevabı gör

doğru cevap: 1 hafta arayla toplam 2 seans

açıklama: Protokolde 8 mL %12.5 dekstroz + 40 mg %2 lidokain, 1 hafta arayla 2 seans halinde uygulanmistir.

Mofrad MK, Rezasoltani Z, Dadarkhah A, et al. J Clin Rheumatol 2021;27(4):e134-e138 PMID 32975923

omuz zor

Mofrad RKC'sinde neurofasial dekstroz ile fizyoterapi karsilastirilmistir.

Mofrad RKC'sinde neurofasial dekstroz enjeksiyonunun fizyoterapiye kiyasla etkinligi zaman icinde nasil seyretmistir?

cevabı gör

doğru cevap: 2. haftada agri ve dizabilitede ustun, 3. ayda agri acisindan benzer (p=0.055)

açıklama: Neurofasial dekstroz fizyoterapiye gore 2. haftada agri ve dizabilitede ustun bulunmus, 3. ayda agri acisindan benzerlesmistir (p=0.055); kisa donem avantaji sunar.

Mofrad MK, Rezasoltani Z, Dadarkhah A, et al. J Clin Rheumatol 2021;27(4):e134-e138 PMID 32975923

omuz orta

Periartikuler/neurofasial teknik ile suprascapular sinir trasesine enjeksiyon planlaniyor.

Neurofasial omuz proloterapisinde suprascapular sinir trasesine enjeksiyon yapilirken, bu yapinin ozelligi nedir?

cevabı gör

doğru cevap: Hem terapotik hedef hem de intranöral/vaskuler yaralanma acisindan komsu risk yapisidir

açıklama: Suprascapular sinir hem terapotik hedef hem de intranöral/vaskuler yaralanma acisindan komsu risktir; ayrica aksiller sinir ve suprascapular arter risk altindadir, ultrason kilavuzlugu onerilir.

Mofrad MK, et al. J Clin Rheumatol 2021;27(4):e134-e138 PMID 32975923

tüm makaleler ve soru çözme →

"What we know is a drop, what we don't know is an ocean." - Isaac Newton✧ ˚ · ✦ · ˚ ✧@damlahelloworlddamla